Citations

Showing 10 of 108081 citations.

Apparent Behavioral Benefits of Tau Overexpression in P301L Tau Transgenic Mice
Morgan, Dave, Munireddy, Sanjay, Alamed, Jennifer, DeLeon, Jason, Diamond, David M. , Hutton, Michael , Lewis, Jada , Gordon, Marcia N. , Bickford, Paula C. , McGowan, Eileen

Mayo Clinic

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 15 | Issue: 4 | Pages: 605-614

10.3233/jad-2008-15407 | PMID 19096159 Get It

Immunoresponsive Autonomic Neuropathy in Sjögren Syndrome—Case Series and Literature Review
Goodman, Brent P.

Mayo Clinic

American Journal of Therapeutics | April 5, 2017 | Volume: 26 | Issue: 1 | Pages: e66-e71

10.1097/mjt.0000000000000583 | PMID 28379880 Get It

Background: Sjögren syndrome (SS) is one of the most common autoimmune disorders that classically affects exocrine glands, resulting in keratoconjunctivitis sicca and xerostomia, and frequently is associated with other systemic symptoms. SS appears to have a particular predilection for involving the autonomic nervous system. Study Question: Does immunotherapy improve signs and symptoms of autonomic nervous system impairment in SS? Study Design: This is a retrospective review of patients seen in the autonomic clinic at our institution who underwent an evaluation for a suspected autonomic disorder that ultimately was attributed to SS. SS patients who were treated with immunotherapy and completed autonomic testing before and after treatment were included in this review. Results: A total of 4 patients were identified who were treated for SS-related autonomic dysfunction with immunotherapy and underwent repeat autonomic testing after treatment. Marked clinical and functional improvement was seen after treatment with intravenous immunoglobulin in all patients and adjunctive rituximab therapy in 1 patient. The clinical improvement with immunotherapy in these patients correlated with markedly improved findings on autonomic testing in all. Measures and Outcomes: Clinical symptoms and results of autonomic testing prior to and following immunotherapy were assessed. Conclusions: Autonomic signs and symptoms in SS are potentially immunoresponsive, but immunotherapy in these patients may require repeated, ongoing, or adjunctive therapy for optimal and sustained improvement.
Extent of diagnostic agreement among medical referrals
Such, Monica Van , Lohr, Robert H., Beckman, Thomas J. , Naessens, James M. , Van Such, Monica , Lohr, Robert, Beckman, Thomas

Mayo Clinic

Journal of Evaluation in Clinical Practice | April 5, 2017 | Volume: 23 | Issue: 4 | Pages: 870-874

10.1111/jep.12747 | PMID 28374457 Get It

AbstractRationale, aims and objectivesDiagnostic uncertainty is often encountered in a medical practice. Patients with ambiguous, uncertain, and undiagnosed problems are frequently referred for second opinions. Comparing referral diagnoses to final diagnoses provides an opportunity to determine how frequently final diagnoses vary and changes the direction of medical care.MethodsA retrospective study was done at a single academic medical center using a sample of 286 patients referred by physician assistants, nurse practitioners, and physicians from primary care practices from January 1, 2009 to December 31, 2010. Patients' referral and final diagnoses were compared and classified into 1 of 3 categories: referral diagnosis and final diagnosis the same, referral diagnosis better defined/refined, and referral diagnosis distinctly different from final diagnosis. Episode costs for the respective categories were calculated for the referral visit and services that occurred at our facility within the first 30 days.ResultsIn 12% (36/286) of cases, referral diagnoses were the same as final diagnoses. Final diagnoses were better defined/refined in 66% (188/286) of cases; but in 21% of cases (62/286), final diagnoses were distinctly different than referral diagnoses. Total costs for cases in category 3 (different final diagnoses) were significantly higher than costs for cases in category 1 (P = .0001) and category 2 (P = <.0001).ConclusionReferrals to advanced specialty care for undifferentiated problems are an essential component of patient care. Without adequate resources to handle undifferentiated diagnoses, a potential unintended consequence is misdiagnoses resulting in treatment delays and complications leading to more costly treatments.
Differential Incorporation of Tau Isoforms in Alzheimer's Disease
Espinoza, Marisol, Silva, Rohan de , Dickson, Dennis W. , Davies, Peter

Mayo Clinic

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 14 | Issue: 1 | Pages: 1-16

10.3233/jad-2008-14101 | PMID 18525123 Get It

Inhibition of PHF-like Tau Hyperphosphorylation in SH-SY5Y Cells and Rat Brain Slices by K252a
Hübinger, Gabriele, Geis, Silvia, LeCorre, Sylvie, Mühlbacher, Susanne, Fracasso, Rafael , Hoffman, F.O. , Ferrand, Sandrine, Klafki, Hans‐Wolfgang , Roder, Hanno M., Gordon, Sandra Leigh

Mayo Clinic

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 13 | Issue: 3 | Pages: 281-294

10.3233/jad-2008-13306 | PMID 18430996 Get It

Cognitive Performance Correlates with Cortical Isopeptide Immunoreactivity as Well as Alzheimer Type Pathology
Wang, Deng-Shun, Uchikado, Hirotake, Bennett, David A. , Mufson, Elliott J. , Bennett, David A. , Schneider, Julie A. , Wu, Joanne , Dickson, Dennis W.

Mayo Clinic

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 13 | Issue: 1 | Pages: 53-66

10.3233/jad-2008-13106 | PMID 18334757 Get It

Mild Cognitive Impairment: Is it Alzheimer's disease or Not?
Petersen, Ronald C. , Bennett, David A. , Bennett, David A.

Mayo Clinic

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 7 | Issue: 3 | Pages: 241-245

10.3233/jad-2005-7307 | PMID 16006668 Get It

Assembly of filamentous tau aggregates in human neuronal cells
Ko, Li‐wen, Rush, Toni, Kersh, Jay S., Easson, Colin, DeTure, Michael , Lin, Wen-Lang, Connor, Yamicia , Yen, Shu-Hui, Sahara, Naruhiko

Mayo Clinic

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 6 | Issue: 6 | Pages: 605-622

10.3233/jad-2004-6605 | PMID 15665401 Get It

Iliopsoas Impingement After Primary Total Hip Arthroplasty: Operative and Nonoperative Treatment Outcomes
Sculco, Peter K. , Trousdale, Robert T. , Berry, Daniel J. , Chalmers, Brian P. , Sierra, Rafael J. , Berry, Daniel J

Mayo Clinic

Journal of Bone and Joint Surgery | April 5, 2017 | Volume: 99 | Issue: 7 | Pages: 557-564

10.2106/jbjs.16.00244 | PMID 28375888 Get It

Background: A potential cause of persistent groin pain after total hip arthroplasty is impingement of the iliopsoas tendon. Treatment options include conservative management, tenotomy, and acetabular revision, but the literature, to our knowledge, has been limited to small case series on each technique. We present a series of patients with iliopsoas impingement after total hip arthroplasty and evaluate efficacy and risk factors for success or failure of each treatment strategy. Methods: Forty-nine patients treated at one institution for a diagnosis of iliopsoas impingement after primary total hip arthroplasty with hemispherical acetabular component and polyethylene bearing were retrospectively reviewed. Twenty-one patients underwent acetabular revision, 8 patients underwent tenotomy, and 20 patients had nonoperative management. The mean follow-up was 4 years. Anterior acetabular component prominence was measured on true lateral hip radiographs. Results: At the most recent follow-up, 10 patients (50%) in the nonoperative group had groin pain resolution compared with 22 patients (76%) in the operative group (p = 0.06). In patients with <8 mm of component prominence, tenotomy provided resolution of groin pain in 5 (100%) of 5 patients and a mean Harris hip score of 89 points. In patients with ≥8 mm of prominence, acetabular revision led to groin pain resolution in 12 (92%) of 13 patients compared with 1 (33%) of 3 patients treated with tenotomy (p = 0.07). Conclusions: Nonoperative management of iliopsoas impingement led to groin pain resolution in 50% of patients. In patients with minimal acetabular component prominence, iliopsoas release provided a high rate of success. Acetabular revision was more predictable for groin pain resolution in patients with ≥8 mm of anterior component prominence. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
Unplanned Readmissions Following Outpatient Hand and Elbow Surgery
Noureldin, Mohamed , Habermann, Elizabeth B. , Ubl, Daniel S. , Kakar, Sanjeev , Habermann, Elizabeth

Mayo Clinic

Journal of Bone and Joint Surgery | April 5, 2017 | Volume: 99 | Issue: 7 | Pages: 541-549

10.2106/jbjs.15.01423 | PMID 28375886 Get It

Background: Unplanned readmission following surgery is a quality metric that helps surgeons assess initiatives targeted at improving patient care. We utilized the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database to determine the rates, causes, and predictors of unplanned 30-day readmissions after outpatient elective hand and elbow surgery. Methods: The ACS-NSQIP database was queried using hand-and-elbow-specific Current Procedural Terminology (CPT) codes to retrospectively identify patients who had undergone outpatient hand or elbow surgery in 2012 and 2013. Patients who required an unplanned readmission to the hospital within 30 days were compared with those who were not readmitted. Preoperative patient characteristics, intraoperative variables, complications, and mortality were compared between the cohorts. Cox proportional hazard models were used to determine independent associations with 30-day unplanned readmission. Results: A total of 14,106 outpatient hand or elbow surgery procedures were identified between 2012 and 2013, and 169 (1.2%) of them were followed by an unplanned readmission. The leading causes of readmission included postoperative infections (19.5%), pain (4.7%), thromboembolic events (4.1%), and pulmonary complications (3.0%). The causes of approximately 1/3 of the readmissions were missing from the database, and these readmissions were likely unrelated to the principal procedure. Independent predictors of readmission included an age of 70 to 84 years (hazard ratio [HR] = 2.83, 95% confidence interval [CI] = 1.67 to 4.78), smoking (HR = 2.23, 95% CI = 1.57 to 3.18), a lower hematocrit (HR = 2.19, 95% CI = 1.38 to 3.46), renal dialysis (HR = 3.32, 95% CI = 1.60 to 6.91), and an elbow procedure (with or without a hand procedure) (HR = 2.19, 95% CI = 1.57 to 3.04). Conclusions: The prevalence of unplanned readmission following outpatient hand and elbow surgery is low. Several modifiable factors, including preoperative smoking and anemia, are associated with unplanned readmission. These data may be helpful in developing quality-control initiatives to target unplanned readmissions following hand and elbow procedures. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.